Literature DB >> 26322851

Upregulation and Mitochondrial Sequestration of Hemoglobin Occur in Circulating Leukocytes during Critical Illness, Conferring a Cytoprotective Phenotype.

Attila Brunyanszki1, Katalin Erdelyi1, Bartosz Szczesny1,2, Gabor Olah1, Reinaldo Salomao3, David N Herndon2,4, Csaba Szabo1,2.   

Abstract

The classical role of hemoglobin in the erythrocytes is to carry oxygen from the lungs to the tissues via the circulation. However, hemoglobin also acts as a redox regulator and as a scavenger of the gaseous mediators nitric oxide (NO) and hydrogen sulfide (H2S). Here we show that upregulation of hemoglobin (α, β and δ variants of globin proteins) occurs in human peripheral blood mononuclear cells (PBMCs) in critical illness (patients with severe third-degree burn injury and patients with sepsis). The increase in intracellular hemoglobin concentration is a result of a combination of enhanced protein expression and uptake from the extra-cellular space via a CD163-dependent mechanism. Intracellular hemoglobin preferentially localizes to the mitochondria, where it interacts with complex I and, on the one hand, increases mitochondrial respiratory rate and mitochondrial membrane potential, and on the other hand, protects from H2O2-induced cytotoxicity and mitochondrial DNA damage. Both burn injury and sepsis were associated with increased plasma levels of H2S. Incubation of mononuclear cells with H2S induced hemoglobin mRNA upregulation in PBMCs in vitro. Intracellular hemoglobin upregulation conferred a protective effect against cell dysfunction elicited by H2S. Hemoglobin uptake also was associated with a protection from, and induced the upregulation of, HIF-1α and Nrf2 mRNA. In conclusion, PBMCs in critical illness upregulate their intracellular hemoglobin levels by a combination of active synthesis and uptake from the extracellular medium. We propose that this process serves as a defense mechanism protecting the cell against cytotoxic concentrations of H2S and other gaseous transmitters, oxidants and free radicals produced in critically ill patients.

Entities:  

Year:  2015        PMID: 26322851      PMCID: PMC4749489          DOI: 10.2119/molmed.2015.00187

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  41 in total

Review 1.  Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.

Authors:  Gregg L Semenza
Journal:  Biochim Biophys Acta       Date:  2010-08-21

2.  On the combination of nitric oxide with haemoglobin.

Authors:  M L Anson; A E Mirsky
Journal:  J Physiol       Date:  1925-05-21       Impact factor: 5.182

3.  Hemoglobin induction in mouse macrophages.

Authors:  L Liu; M Zeng; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

5.  Analysis of the mitochondrial proteome in multiple sclerosis cortex.

Authors:  Laurie Broadwater; Ashish Pandit; Robert Clements; Sausan Azzam; Jonathan Vadnal; Michael Sulak; V Wee Yong; Ernest J Freeman; Roger B Gregory; Jennifer McDonough
Journal:  Biochim Biophys Acta       Date:  2011-02-02

6.  Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid.

Authors:  Ciro Coletta; Katalin Módis; Bartosz Szczesny; Attila Brunyánszki; Gábor Oláh; Ester C S Rios; Kazunori Yanagi; Akbar Ahmad; Andreas Papapetropoulos; Csaba Szabo
Journal:  Mol Med       Date:  2015-02-18       Impact factor: 6.354

7.  Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells.

Authors:  Marta Biagioli; Milena Pinto; Daniela Cesselli; Marta Zaninello; Dejan Lazarevic; Paola Roncaglia; Roberto Simone; Christina Vlachouli; Charles Plessy; Nicolas Bertin; Antonio Beltrami; Kazuto Kobayashi; Vittorio Gallo; Claudio Santoro; Isidro Ferrer; Stefano Rivella; Carlo Alberto Beltrami; Piero Carninci; Elio Raviola; Stefano Gustincich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 8.  Potential role of hydrogen sulfide in the pathogenesis of vascular dysfunction in septic shock.

Authors:  Ciro Coletta; Csaba Szabo
Journal:  Curr Vasc Pharmacol       Date:  2013-03-01       Impact factor: 2.719

9.  Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis.

Authors:  Milena Karina Colo Brunialti; Michelle Carolina Santos; Otelo Rigato; Flavia Ribeiro Machado; Eliezer Silva; Reinaldo Salomao
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 10.  Extracellular hemoglobin: the case of a friend turned foe.

Authors:  Isaac K Quaye
Journal:  Front Physiol       Date:  2015-04-20       Impact factor: 4.566

View more
  9 in total

1.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

2.  Delayed Treatment with Sodium Hydrosulfide Improves Regional Blood Flow and Alleviates Cecal Ligation and Puncture (CLP)-Induced Septic Shock.

Authors:  Akbar Ahmad; Nadiya Druzhyna; Csaba Szabo
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

3.  S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics.

Authors:  Katalin Módis; YoungJun Ju; Akbar Ahmad; Ashley A Untereiner; Zaid Altaany; Lingyun Wu; Csaba Szabo; Rui Wang
Journal:  Pharmacol Res       Date:  2016-08-20       Impact factor: 7.658

Review 4.  The role of globins in cardiovascular physiology.

Authors:  T C Stevenson Keller; Christophe Lechauve; Alexander S Keller; Steven Brooks; Mitchell J Weiss; Linda Columbus; Hans Ackerman; Miriam M Cortese-Krott; Brant E Isakson
Journal:  Physiol Rev       Date:  2021-09-06       Impact factor: 37.312

Review 5.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

6.  Effect of endotoxemia in mice genetically deficient in cystathionine-γ-lyase, cystathionine-β-synthase or 3-mercaptopyruvate sulfurtransferase.

Authors:  Akbar Ahmad; Domokos Gerö; Gabor Olah; Csaba Szabo
Journal:  Int J Mol Med       Date:  2016-10-14       Impact factor: 4.101

7.  Genetic signature related to heme-hemoglobin metabolism pathway in sepsis secondary to pneumonia.

Authors:  Giuseppe Gianini Figuerêido Leite; Brendon P Scicluna; Tom van der Poll; Reinaldo Salomão
Journal:  NPJ Syst Biol Appl       Date:  2019-08-01

8.  Analysis of Mitochondrial haemoglobin in Parkinson's disease brain.

Authors:  Freya Shephard; Oliver Greville-Heygate; Susan Liddell; Richard Emes; Lisa Chakrabarti
Journal:  Mitochondrion       Date:  2016-05-12       Impact factor: 4.160

9.  The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters.

Authors:  Afshin Derakhshani; Hossein Safarpour; Mahdi Abdoli Shadbad; Nima Hemmat; Patrizia Leone; Zahra Asadzadeh; Mehrdad Pashazadeh; Behzad Baradaran; Vito Racanelli
Journal:  Front Immunol       Date:  2021-08-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.